A Review of Nuclear Medicine Approaches in the Diagnosis and the Treatment of Gynecological Malignancies
Nuclear medicine is defined as the diagnosis and the treatment of disease using radiolabeled compounds known as radiopharmaceuticals. Single-photon emission computed tomography/computed tomography (SPECT/CT) and positron emission tomography/computer tomography (PET/CT) based radiopharmaceuticals hav...
Main Authors: | Nasim Vahidfar, Saeed Farzanefar, Hojjat Ahmadzadehfar, Eóin N. Molloy, Elisabeth Eppard |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/7/1779 |
Similar Items
-
Molecular imaging in oncology: Common PET/CT radiopharmaceuticals and applications
by: Elisa Franquet, et al.
Published: (2022-01-01) -
Tumor Hypoxia Imaging Agents in Nuclear Medicine
by: Mahtab Mohammadpour, et al.
Published: (2017-01-01) -
Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders—An Update
by: Jonatan Dewulf, et al.
Published: (2020-07-01) -
Positron Emission Tomography Radiopharmaceuticals in Differentiated Thyroid Cancer
by: Chaninart Sakulpisuti, et al.
Published: (2022-08-01) -
In-111 octreotide SPECT/CT in the early diagnosis of pulmonary sarcoidosis: A case report
by: Roberto G. Carbone, MD, et al.
Published: (2022-02-01)